Cannabis Industry Sees Steady Growth Amid Federal Reclassification Hopes
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
Regulatory shifts dominate: Virginia's Boones Mill schedules the state's first public hearing on retail cannabis sales today, January 12, ahead of General Assembly legalization expected soon, aiming to avoid black market opt-outs.[5] Texas proposes massive fee hikes, jumping retail registrations from 150 to 20,000 dollars per location, with comments due by January 26.[9] Federally, Trump's December executive order for Schedule III reclassification boosts stocks like Glass House Brands, up 59.7 percent post-announcement, easing taxes and banking.[3]
No new deals or launches emerged in the last 48 hours, but Canopy Growth recently overhauled debt for expansion.[8] Consumer behavior holds firm, with potential for on-site use in New York's yoga studios and theaters starting soon.[11] Leaders like Glass House CEO Kyle Kazan anticipate price drops to compete with illicit markets via reduced taxes.[3]
Compared to early January's broader watchlist of seven stocks, focus narrows to three high-volume names, reflecting consolidation.[2][6] Hawaii's expo announcement for late January underscores wellness education growth.[1] Supply chains see no acute issues, though Virginia eyes repurposing facilities like AeroFarms for cultivation.[5] Overall, optimism builds on policy tailwinds, with leaders pivoting to compliance and scale.
(Word count: 278)
For great deals today, check out https://amzn.to/44ci4hQ
This content was created in partnership and with the help of Artificial Intelligence AI
Todavía no hay opiniones